Heparin — Drug Intelligence | 6 EU Trials

Filter these 6 trials by condition, phase, country and more.

6 Registered trials

1 Recruiting

0 Completed trials

5 Sponsors

4 Countries

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 2 Phase IV: 2

Oversight events:

3 temporary halts 2 urgent safety measures across 3 trials

Indications tested

6 total

RATE: Reduced anticoagulation targets in extracorporeal life support Pending

2023-509675-16-01 Phase III 1 country Universitair Medisch Centrum Groningen
STRATIFY II Pending

2024-515712-45-00 Phase IV 1 country Rigshospitalet
PALETTE - Trial for personalisation of sepsis treatment in children and adults Pending

2025-521371-31-00 Phase II 1 country Assistance Publique Hopitaux De Paris
Trans-arterial treatment of patients with intra-hepatic cholangiocarcinoma not amenable to resection (TOMCAT) Recruiting

2023-504433-50-00 Phase IV 1 country Oslo University Hospital HF
Extended Criteria Treatment for Liver Metastases With Heavy Tumour Burden Halted

2024-512397-95-00 Phase II 1 country Oslo University Hospital HF
PUMP-IT RCT: Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy f… Halted

2023-506194-35-00 Phase III 1 country Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Showing 1–6 of 6 trials